COMPANY

A growing business

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world.

We are an industry leader in producing plasma-derived medicines and transfusion medicine.

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies.

We sell our products and services in more than 100 countries and regions and have subsidiaries in more than 30 of them.

We aim to be a global leader in our markets and an industry reference for quality, safety, and innovation.  

5.3
billion

revenue

24000
employees

298
million

R+D+i investments

5.3
billion

revenue

24000
employees

298
million

R+D+i investments

 

Grifols' history of growth demonstrates its capacity to evolve and make a positive impact on society. We take great pride in our ethical approach and work diligently to ensure the safety of our products."

Raimon Grifols, CEO

 

At Grifols, we think and act with a long-term, sustainable, and responsible perspective at every stage of the value chain. We place donors and patients at the heart of our activities to improve people's well-being.

Víctor Grifols Deu, CEO

Grifols' global presence

Grifols is a growing global company. We have subsidiaries in more than 30 countries and regions and 16 manufacturing plants around the world. Our long-term vision allows us to continue exploring new markets and regions and to increase our growing workforce. Our nearly 24,000 employees work for a common goal: to improve people's lives and well-being.